Creates a pilot grant program for 10 states to implement programs to identify uninsured diabetes patients and provide them with insulin at $35 a month.
Will create a pilot grant program for states to identify uninsured diabetes patients and provide them insulin at $35 a month.
Occurrences
Fourteen Senators from each party now cosponsor the Shaheen-led bill to lower insulin costs for Americans with and without insurance.
Evidence
In the lookback window, Axios reported that the Senate health committee gave the insulin measure bipartisan backing by a 15-8 vote when offered as an amendment, but Chairman Bill Cassidy postponed a vote on the underlying measure and said details still needed work. The report says the bill would create a 10-state pilot for uninsured people.
Shaheen's Senate office announced that Shaheen, Collins, Warnock, and Kennedy introduced the INSULIN Act. The announcement says the bill would cap insulin costs for private and employer insurance and create a pilot grant program for 10 states to identify uninsured diabetes patients and provide insulin at $35 a month.
The posted bill text says the Secretary shall conduct a five-year pilot program awarding grants to 10 states to provide affordable insulin to uninsured individuals, defines affordable insulin as not more than $35 per one-month supply, and authorizes $100 million for fiscal year 2027.
At a Senate HELP Committee Member Day, Collins and Shaheen previewed the INSULIN Act. Shaheen's transcribed remarks said the bill would cap employer and private insurance insulin at $35 a month and create a pilot program providing $35-a-month insulin for uninsured diabetes patients.
AP reported that the bipartisan INSULIN Act introduced by Shaheen, Warnock, Collins, and Kennedy would cap private-insurance insulin costs and start a pilot program for uninsured Americans in 10 states. The story also noted the legislation faced hurdles, including cost concerns and competing congressional priorities.
The enacted Inflation Reduction Act added Medicare Part D and Part B insulin cost protections, including a $35 applicable copayment amount for covered insulin products, but those cited sections apply through Medicare rather than creating the 10-state uninsured-patient pilot grant program described in this commitment.
Assessments
Shaheen materially advanced the specific proposal by introducing and advocating for the INSULIN Act, which would create the 10-state pilot grant program for uninsured diabetes patients and $35 monthly insulin. But the evidence shows the measure remained proposed or in committee movement as of July 8, 2026, with no enactment, funding, or implementation of the pilot program. The Inflation Reduction Act delivered related Medicare insulin caps but not the promised uninsured-patient state pilot, so the specific commitment was not fulfilled despite serious effort.